SCHEMBL4725970

SCHEMBL4725970

Cn1c(C=O)nc2cccc(F)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.36
PRMT5 O14744 1/20 0.36
KDM4E B2RXH2 4/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
VDR P11473 1/20 0.35
MAPT P10636 3/20 0.34
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
PKM P14618 1/20 0.34
PARP1 P09874 1/20 0.34
MEN1 O00255 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 2/20 0.33
GAA P10253 2/20 0.33
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4725204 0.80 KDM4E (0.39) PRMT5KDM4ENPC1RAB9AMAPT
SCHEMBL4725201 0.75 PDE10A (0.44) PDE10APRMT5KDM4ENPC1RAB9A
SCHEMBL30893480 0.73 ALDH1A1 (0.44) PDE10AKDM4EMAPTALDH1A1KMT2A
SCHEMBL22894791 0.73 PDE10A (0.36) PDE10AKDM4ENPC1RAB9AMAPT
SCHEMBL10644280 0.72 PDE10A (0.48) PDE10AKDM4ENPC1RAB9AVDR
SCHEMBL102893 0.72 KDM4E (0.64) PDE10AKDM4ENPC1RAB9AMAPT
SCHEMBL22894846 0.71 PDE10A (0.37) PDE10APRMT5KDM4EALDH1A1KMT2A
SCHEMBL12263309 0.71 MEN1 (0.47) PDE10APRMT5KDM4ENPC1RAB9A
Hydrochloric Acid SCHEMBL5439722 0.71 PDE10A (0.34) PDE10AKDM4ENPC1RAB9AMAPT
SCHEMBL6870350 0.69 ALOX15 (0.53) KDM4ENPC1RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280933-A1 BENZIMIDAZOLYL COMPOUNDS EFREMOV IVAN 2008-11-13 US disclosed
WO-2008012623-A1 BENZIMIDAZOLYL COMPOUNDS AS POTENTIATORS OF MGLUR2 SUBTYPE OF GLUTAMATE RECEPTOR PFIZER PRODUCTS INC. (US) 2008-01-31 WO disclosed
US-4782050-A BACTERICIDES PFIZER INC. (US) 1988-11-01 US disclosed
EP-0276942-A1 6-Beta(substituted)-(S)-hydroxymethylpenicillanic acids and derivatives thereof PFIZER INC. (US) 1988-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280933-A1 BENZIMIDAZOLYL COMPOUNDS PAICS, TMBIM6, ABCG2 PDE10A 93/4885PRMT5 2797/4885KDM4E 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.